Baird Financial Group, Inc. Alkermes Plc. Transaction History

Baird Financial Group, Inc.

  • $50.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$21.47 - $32.08 $324,454 - $484,792
-15,112 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$23.37 - $32.13 $353,167 - $485,548
15,112 New
15,112 $466,000
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $144,190 - $182,584
-3,555 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$53.61 - $67.26 $190,583 - $239,109
3,555 New
3,555 $206,000

Others Institutions Holding ALKS

# of Institutions
363
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.72B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email